• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does a patient's sex predict the efficacy of cancer immunotherapy?

作者信息

Abdel-Rahman Omar

机构信息

Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary T2N 1N4, AB, Canada.

出版信息

Lancet Oncol. 2018 Jun;19(6):716-717. doi: 10.1016/S1470-2045(18)30270-5. Epub 2018 May 16.

DOI:10.1016/S1470-2045(18)30270-5
PMID:29778735
Abstract
摘要

相似文献

1
Does a patient's sex predict the efficacy of cancer immunotherapy?患者的性别能否预测癌症免疫疗法的疗效？
Lancet Oncol. 2018 Jun;19(6):716-717. doi: 10.1016/S1470-2045(18)30270-5. Epub 2018 May 16.
2
Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.癌症的检查点免疫疗法：卓越的生存率，罕见的毒性反应
Intern Med J. 2015 Jul;45(7):696-701. doi: 10.1111/imj.12653.
3
Patient's T cells target tumor mutation.患者的 T 细胞靶向肿瘤突变。
Cancer Discov. 2014 Jul;4(7):751. doi: 10.1158/2159-8290.CD-NB2014-079. Epub 2014 May 29.
4
Mutanome directed cancer immunotherapy.基于肿瘤突变组的癌症免疫治疗。
Curr Opin Immunol. 2016 Apr;39:14-22. doi: 10.1016/j.coi.2015.12.001. Epub 2015 Dec 21.
5
Immunoengineering with biomaterials for enhanced cancer immunotherapy.生物材料在增强癌症免疫治疗中的免疫工程学应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jul;10(4):e1506. doi: 10.1002/wnan.1506. Epub 2018 Jan 14.
6
The swinging pendulum of cancer immunotherapy personalization.癌症免疫治疗个性化的摆动钟摆。
Per Med. 2017 May;14(3):259-270. doi: 10.2217/pme-2016-0108. Epub 2017 May 5.
7
Cancer Nanomedicine: Lessons for Immuno-Oncology.癌症纳米医学：免疫肿瘤学的经验教训
Trends Cancer. 2017 Aug;3(8):551-560. doi: 10.1016/j.trecan.2017.06.006. Epub 2017 Jul 23.
8
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.用数学和计算建模应对癌症免疫治疗中的当前挑战。
J R Soc Interface. 2017 Jun;14(131). doi: 10.1098/rsif.2017.0150.
9
Targeting iNOS to increase efficacy of immunotherapies.靶向诱导型一氧化氮合酶以提高免疫疗法的疗效。
Hum Vaccin Immunother. 2017 May 4;13(5):1105-1108. doi: 10.1080/21645515.2016.1276682. Epub 2017 Jan 25.
10
Active Immunotherapy of Cancer.癌症的主动免疫疗法
Immunol Invest. 2015;44(8):817-36. doi: 10.3109/08820139.2015.1096684.

引用本文的文献

1
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.与免疫检查点抑制剂相关的神经学表现：利用欧洲真实世界安全数据进行的反向转化研究
Front Oncol. 2022 Mar 15;12:824511. doi: 10.3389/fonc.2022.824511. eCollection 2022.
2
Sex Differences in Immunity.性别与免疫差异。
Annu Rev Immunol. 2022 Apr 26;40:75-94. doi: 10.1146/annurev-immunol-101320-125133. Epub 2022 Jan 5.
3
Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer.
新辅助/围手术期治疗影响胃癌中肿瘤相关中性粒细胞和CD8+淋巴细胞的空间分布及密度。
J Pers Med. 2021 Nov 12;11(11):1184. doi: 10.3390/jpm11111184.
4
The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review.免疫检查点抑制剂治疗后肺部毒性的已知与未知：一篇叙述性综述
Transl Lung Cancer Res. 2021 Jun;10(6):2752-2765. doi: 10.21037/tlcr-20-806.
5
Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review.免疫检查点抑制剂在非小细胞肺癌治疗中的心脏毒性：综述。
Int J Mol Sci. 2020 Sep 29;21(19):7195. doi: 10.3390/ijms21197195.
6
Sex and Gender Influences on Cancer Immunotherapy Response.性别对癌症免疫治疗反应的影响。
Biomedicines. 2020 Jul 21;8(7):232. doi: 10.3390/biomedicines8070232.
7
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.癌症中的免疫代谢与微环境：免疫治疗的关键因素。
Int J Mol Sci. 2020 Jun 21;21(12):4414. doi: 10.3390/ijms21124414.
8
Sex-associated molecular differences for cancer immunotherapy.癌症免疫治疗的性别相关分子差异。
Nat Commun. 2020 Apr 14;11(1):1779. doi: 10.1038/s41467-020-15679-x.
9
Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer.临床病理特征对晚期肺癌患者免疫检查点抑制剂联合传统治疗疗效的影响。
J Thorac Dis. 2019 Sep;11(9):3794-3807. doi: 10.21037/jtd.2019.09.19.
10
Managing cardiotoxicity associated with immune checkpoint inhibitors.应对与免疫检查点抑制剂相关的心脏毒性
Chronic Dis Transl Med. 2019 Mar 21;5(1):6-14. doi: 10.1016/j.cdtm.2019.02.004. eCollection 2019 Mar.